Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth
Journal Article
·
· Biochemical and Biophysical Research Communications
- Department of Oncology and Pathology, Karolinska Institute, CCK, R8:04, S-17176 Stockholm (Sweden)
- Department of Clinical Chemistry, Karolinska Hospital, Stockholm (Sweden)
Recently we demonstrated that the synovial sarcoma specific fusion gene SS18-SSX is crucial for cyclin D1 expression and is linked to cell proliferation. In this report we explore the role of SS18-SSX and IGF-1R for their potential functions in cellular proliferation and survival in cultured synovial sarcoma cells. We found that targeting of SS18-SSX mRNA by antisense oligonucleotide treatment drastically and rapidly decreased cell proliferation but caused only a slight increase of apoptosis. The synovial sarcoma cells were confirmed to express IGF-1R, and treatment with an IGF-1R inhibitor resulted in substantially reduced cell viability by inducing apoptosis in these cells. Conversely, inhibition of the IGF-1R resulted only in a slight to moderate decrease in DNA synthesis. In conclusion, SS18-SSX and IGF-1R seem to play important but different roles in maintaining malignant growth of synovial sarcoma cells. Whereas SS18-SSX maintains cyclin D1 and cell proliferation, IGF-1R protects from apoptosis.
- OSTI ID:
- 21043708
- Journal Information:
- Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 3 Vol. 368; ISSN 0006-291X; ISSN BBRCA9
- Country of Publication:
- United States
- Language:
- English
Similar Records
Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor
Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-1 receptor signaling pathways
EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells
Journal Article
·
Fri May 22 00:00:00 EDT 2015
· Biochemical and Biophysical Research Communications
·
OSTI ID:22462055
Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-1 receptor signaling pathways
Journal Article
·
Fri Nov 01 00:00:00 EDT 2013
· Toxicology and Applied Pharmacology
·
OSTI ID:22285456
EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells
Journal Article
·
Fri Sep 02 00:00:00 EDT 2005
· Biochemical and Biophysical Research Communications
·
OSTI ID:20710949